Jane Street’s EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant EQHA.U Stock Holding History

Jane Street’s Portfolio EQHA.U Stock Details EQHA.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-20,023	Closed	-$198K	–	10630
2022 Q3	$198K	Hold	20,023	–	–	﹤0.01%	8190
2022 Q2	$197K	Sell	20,023 -769	-4%	-$7.6K	﹤0.01%	8203
2022 Q1	$205K	Buy	20,792 +253	+1%	+$2.51K	﹤0.01%	9005
2021 Q4	$201K	Buy	20,539 +516	+3%	+$5.18K	﹤0.01%	8815
2021 Q3	$200K	Hold	20,023	–	–	﹤0.01%	8849
2021 Q2	$200K	Buy	+20,023	New	+$200K	﹤0.01%	8833

Jane Street's EQHA.U Position: Q4 2022 in Review

Jane Street sold out of EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant (EQHA.U) in Q4 2022, closing a stake of 20,023 shares — an estimated $198K sold.

Jane Street first reported a position in EQHA.U in Q2 2021 and held it in 6 quarters. The position peaked at $205K in Q1 2022. 0 funds tracked by Wall St. Rank hold EQHA.U as of Q4 2022.

Jane Street reported no remaining EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position as of Q4 2022 after selling out during the quarter.
Jane Street sold 20,023 EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant shares in Q4 2022, an estimated $198K.
Jane Street first reported a position in EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant in Q2 2021 and held it in 6 quarters.
Jane Street's EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position peaked at $205K in Q1 2022.
0 funds tracked by Wall St. Rank held EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant as of Q4 2022.

Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.